Hurt R D, Offord K P, Croghan I T, Gomez-Dahl L, Kottke T E, Morse R M, Melton L J
Nicotine Dependence Center, Mayo Clinic, Rochester MN 55905, USA.
JAMA. 1996 Apr 10;275(14):1097-103. doi: 10.1001/jama.275.14.1097.
To determine the impact of tobacco- and alcohol-related deaths on overall mortality following inpatient treatment for alcoholism and other nonnicotine drugs of dependence.
Population-based retrospective cohort study.
Olmsted County, Minnesota (the Rochester Epidemiology Project), and the Inpatient Addiction Program (IAP) at Mayo Clinic, Rochester.
All 845 Olmsted County residents admitted to an inpatient addiction program for treatment of alcoholism and other nonnicotine drugs of dependence during the period 1972 through 1983.
Patients were followed up through the medical record linkage system of the Rochester Epidemiology Project through December 1994 to obtain vital status, and death certificates were obtained for those who died. The underlying cause of death was classified as alcohol related, tobacco related, both, or neither based on the classification from the Centers for Disease Control and Prevention. The observed number of deaths by underlying cause were compared with the expected number using cause-specific 1987 death rates for the white population of the United States. All-cause mortality was also compared with that expected for persons in the West North Central Region of the United States of like age, sex, and year of birth. Univariate and multivariate assessments were made to identify predictors of all-cause mortality from baseline demographic information.
At admission, the mean (SD) age of the 845 patients was 41.4 (14.5) years, and 35% were women. Altogether, 78% had alcohol as their only nonnicotine drug of dependence and 18% had alcohol and other nonnicotine drugs of dependence, while 4% were classified as having a nonalcohol, nonnicotine drug dependence alone. At admission, 75% were current and 8% former cigarette smokers, 3% were current cigar or pipe smokers, and 2% were current users of smokeless tobacco. Follow-up after the index IAP admission totaled 8913 person-years (mean [SD] of 10.5 [5.6] years per patient). Death certificates were obtained for 96% (214) of the 222 patients who died. Of these 214 deaths, 50.9% (109) had a tobacco-related and 34.1% (73) had an alcohol-related underlying cause (P<.001). The cumulative mortality significantly exceeded that expected (P<.001); at 20 years, the observed mortality was 48.1% vs an expected 18.5%. Multivariate predictors of mortality, even after adjusting for expected mortality, were older age at admission (P<.001) and male sex (P<.001).
Patients previously treated for alcoholism and/or other nonnicotine drug dependence had an increased cumulative mortality that was due more to tobacco-related than to alcohol-related causes. Nicotine dependence treatment is imperative in such high-risk patients.
确定酒精和烟草相关死亡对酒精成瘾及其他非尼古丁类药物依赖住院治疗后总体死亡率的影响。
基于人群的回顾性队列研究。
明尼苏达州奥尔姆斯特德县(罗切斯特流行病学项目)以及罗切斯特梅奥诊所的住院成瘾项目(IAP)。
1972年至1983年期间,所有845名入住住院成瘾项目接受酒精成瘾及其他非尼古丁类药物依赖治疗的奥尔姆斯特德县居民。
通过罗切斯特流行病学项目的病历链接系统对患者进行随访,直至1994年12月以获取生命状态信息,为死亡患者获取死亡证明。根据疾病控制与预防中心的分类,将死亡的根本原因分为与酒精相关、与烟草相关、两者皆相关或两者皆不相关。使用美国白人特定病因的1987年死亡率,将观察到的按根本原因分类的死亡人数与预期人数进行比较。全因死亡率也与美国西北中部地区年龄、性别和出生年份相似的人群的预期死亡率进行比较。进行单变量和多变量评估,以从基线人口统计学信息中识别全因死亡率的预测因素。
入院时,845名患者的平均(标准差)年龄为41.4(14.5)岁,35%为女性。总体而言,78%的患者仅对酒精存在非尼古丁类药物依赖,18%的患者对酒精和其他非尼古丁类药物存在依赖,而4%的患者仅被归类为存在非酒精、非尼古丁类药物依赖。入院时,75%为当前吸烟者,8%为既往吸烟者,3%为当前雪茄或烟斗吸烟者,2%为当前无烟烟草使用者。首次IAP入院后的随访总计8913人年(每位患者平均[标准差]为10.5[5.6]年)。222名死亡患者中有96%(21④)获得了死亡证明。在这214例死亡中,50.9%(109例)的根本原因与烟草相关,34.1%(73例)与酒精相关(P<0.001)。累积死亡率显著超过预期(P<0.001);在20年时,观察到的死亡率为48.1%,而预期为18.5%。即使在调整预期死亡率后,死亡率的多变量预测因素仍为入院时年龄较大(P<0.001)和男性(P<0.001)。
先前接受过酒精成瘾和/或其他非尼古丁类药物依赖治疗的患者累积死亡率增加,这更多是由于与烟草相关的原因而非与酒精相关的原因所致。对于此类高危患者,尼古丁依赖治疗势在必行。